What this means
This is a plan to record older patients with blood cancers. It will look at how common frailty and health problems are in them. No results have been shared yet, so it does not show what the researchers will find.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 50 and over · Older adults aged 50 and up with blood cancers, not yet enrolled
- Where
- 1 site, including Alabama
The science
- Registered title
- Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
- Trial ID
- NCT05556928 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Multiple Myeloma, Amyloidosis, Plasma Cell Leukemia
- Sponsor
- University of Alabama at Birmingham
- Ages
- 50 Years to no maximum
- Dates
- First posted Sep 27, 2022 · updated Dec 8, 2025
Registry summary
The primary purpose of this protocol is to create a registry of older (≥50 years old) patients with Hematologic Malignancies. Our main objectives include: To understand the prevalence of frailty and geriatric impairments among patients aged ≥50y and above diagnosed with a hematologic malignancy at UAB and to gather information that would lend support for future research in this vulnerable population.
Sites (1)
- Kirklin Clinic of UAB Hospital, Birmingham, Alabama, United States